Showing results (291-300 of 391) with videos related to

Sort By:
Pageof 40
Journal of Veterinary Pharmacology and Therapeutics|June 7, 2024
In vitro screening model for compound interactions with human and dairy animal BCRP orthologsLérica Le Roux-Pullen, Jeroen J M W Van den Heuvel, Noraly B Jonis, et al.
Molecular Pharmaceutics|March 21, 2012
Exploiting transport activity of p-glycoprotein at the blood-brain barrier for the development of peripheral cannabinoid type 1 receptor antagonistsHanneke G M Wittgen, Rick Greupink, Jeroen J M W van den Heuvel, et al.
Scandinavian Journal of Gastroenterology|December 10, 2020
Cross-cultural translation and validation of the IBD-control questionnaire in The Netherlands: a patient-reported outcome measure in inflammatory bowel diseaseMichiel E de Jong, Erik Taal, Pepijn W A Thomas, et al.
Archives of Toxicology|November 27, 2022
Perfluoroalkyl substances (PFASs) are substrates of the renal human organic anion transporter 4 (OAT4)Jochem Louisse, Luca Dellafiora, Jeroen J M W van den Heuvel, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|January 15, 2019
Uremic solutes modulate hepatic bile acid handling and induce mitochondrial toxicityKarl M Weigand, Tom J J Schirris, Megan Houweling, et al.
Archives of Toxicology|May 25, 2026
Integrated human toxicokinetics of acetamiprid using urine, blood, and feces data in physiologically-based kinetic modelling for reverse dosimetryN C Wieland, A Noorlander, A Zwartsen, et al.
Malaria Journal|October 25, 2017
Proguanil and cycloguanil are organic cation transporter and multidrug and toxin extrusion substratesMaarten van der Velden, Albert Bilos, Jeroen J M W van den Heuvel, et al.
The Journal of Antimicrobial Chemotherapy|November 6, 2015
Placental transfer of the HIV integrase inhibitor dolutegravir in an ex vivo human cotyledon perfusion modelStein Schalkwijk, Rick Greupink, Angela P Colbers, et al.
Plos One|April 13, 2011
Uremic toxins inhibit transport by breast cancer resistance protein and multidrug resistance protein 4 at clinically relevant concentrationsHenricus A M Mutsaers, Lambertus P van den Heuvel, Lauke H J Ringens, et al.
Clinical Pharmacology and Therapeutics|May 15, 2018
Disease-Associated Changes in Drug Transporters May Impact the Pharmacokinetics and/or Toxicity of Drugs: A White Paper From the International Transporter ConsortiumRaymond Evers, Micheline Piquette-Miller, Joseph W Polli, et al.
Pageof 40